JFL Life Sciences P/E Ratio
Current P/E Ratio
4.7
Low Valuation
Very Low - Potentially undervalued or facing challenges
JFL Life Sciences P/E ratio. JFL Life Sciences (JFLLIFE) P/E ratio is 4.7 (Low), EPS (TTM) ₹1.94, current price ₹ on None — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see JFLLIFE share price screener.
Current Valuation Metrics
P/E Ratio
4.7
Current Price
₹
EPS (TTM)
₹1.94
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
52.38
Sector Median
29.6
Sector Rank
#7 of 255
Sector Percentile
2.7%
JFLLIFE P/E Ratio — Valuation Signal & Historical Context
JFL Life Sciences P/E 4.7 — signal: Undervalued. Check JFL Life Sciences market cap to track the company's total market size over time.
- Stock appears undervalued with PE of 4.7, suggesting potential buying opportunity
- Trading at discount to sector average PE of 52.38
JFLLIFE vs Healthcare Peers — P/E Ratio Comparison
JFL Life Sciences P/E 4.7 vs Healthcare average 52.38, median 29.6 — range 2.0–733.0.
Sector Average
52.38
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |
| Colinz Laboratories | COLINZ | 6.5 | ₹17 | Low |